SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Meghmani Finechem gains on commissioning epichlorohydrin plant

02 Jun 2022 Evaluate

Meghmani Finechem is currently trading at Rs. 1445.85, up by 5.45 points or 0.38% from its previous closing of Rs. 1440.40 on the BSE.

The scrip opened at Rs. 1457.80 and has touched a high and low of Rs. 1485.00 and Rs. 1430.00 respectively. So far 17159 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1524.95 on 26-Apr-2022 and a 52 week low of Rs. 386.35 on 18-Aug-2021.

Last one week high and low of the scrip stood at Rs. 1497.05 and Rs. 1223.60 respectively. The current market cap of the company is Rs. 6021.03 crore.

The promoters holding in the company stood at 71.18%, while Institutions and Non-Institutions held 1.51% and 27.31% respectively.

Meghmani Finechem has commissioned plant to produce epichlorohydrin (ECH) with annual capacity of 50,000 tonne. The company is the first company in India to commission a plant for the production of ECH, a chemical compound which is currently imported by the country. The plant has been commissioned on time and without any cost overrun.

In India, approximately 80 per cent of ECH goes into epoxy resin manufacturing, which is further used in industries such as paint, automotive, construction material, windmill, adhesives and electronics. The remaining 20 per cent of the ECH is consumed by the pharmaceuticals industry, for water treatment and paper chemicals, demand for which is also expected to grow significantly.

Meghmani Finechem is primarily engaged in manufacturing and selling of Chlor Alkali & its Derivatives. The Company is also engaged in Trading of Agrochemical products.

Epigral Share Price

1263.25 -37.40 (-2.88%)
12-May-2026 10:41 View Price Chart
Peers
Company Name CMP
BASF India 3827.10
Tata Chemicals 787.00
SRF 2766.70
Pidilite Inds. 1463.70
Deepak Nitrite 1844.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×